OTCMKTS:ARYBU ARYA Sciences Acquisition Corp II (ARYBU) Stock Price, News & Analysis $10.39 -0.11 (-1.05%) As of 10/27/2020 Add Compare Share Share Stock Analysis Stock AnalysisBuy This Stock About ARYA Sciences Acquisition Corp II Stock (OTCMKTS:ARYBU) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get ARYBU alerts:Sign Up Key Stats Today's Range$10.39▼$10.9050-Day Range$10.39▼$10.3952-Week Range$10.00▼$13.46Volume700 shsAverage Volume60,438 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview ARYA Sciences Acquisition Corp II is a special purpose acquisition company (SPAC) incorporated in Delaware in February 2021. The company’s units trade under the ticker ARYBU on the OTC Markets. As a blank‐check vehicle, ARYA Sciences Acquisition Corp II has no commercial operations of its own and was formed to raise capital through an initial public offering for the purpose of effecting a merger, capital stock exchange, asset acquisition or similar business combination. The company is focused on identifying and consummating a business combination with one or more businesses in the biotechnology, life sciences and healthcare technology sectors. ARYA Sciences Acquisition Corp II seeks to leverage its public listing and capital resources to partner with companies that have novel drug candidates, platform technologies or high‐growth service offerings, with an emphasis on organizations positioned to benefit from advances in precision medicine, diagnostics and therapeutics. ARYA Sciences Acquisition Corp II is sponsored by ARYA Sciences LLC, an affiliate of RA Capital Management LP, a Boston‐based life sciences investment firm. The SPAC’s management team includes members of RA Capital’s healthcare investment group, who bring experience in sourcing, evaluating and executing transactions within the global biotech industry. The company is actively evaluating opportunities both in North America and select international markets.AI Generated. May Contain Errors. Read More Receive ARYBU Stock News and Ratings via Email Sign-up to receive the latest news and ratings for ARYA Sciences Acquisition Corp II and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. ARYBU Stock News HeadlinesNo headlines for this company have been tracked by MarketBeat.com ARYBU Stock Analysis - Frequently Asked Questions How have ARYBU shares performed this year? ARYA Sciences Acquisition Corp II's stock was trading at $10.39 on January 1st, 2025. Since then, ARYBU shares have increased by 0.0% and is now trading at $10.39. How do I buy shares of ARYA Sciences Acquisition Corp II? Shares of ARYBU stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Industry, Sector and Symbol Stock ExchangeOTCMKTS SectorFinance Industry Shell Companies Sub-IndustryPharmaceutical Products Current SymbolOTCMKTS:ARYBU CIKN/A WebN/A Phone212 284 2300FaxN/AEmployees300Year FoundedN/AProfitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A Elon Musk's Next MoveExplore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.Get This Free Report This page (OTCMKTS:ARYBU) was last updated on 9/15/2025 by MarketBeat.com Staff From Our PartnersOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredForget AI Stocks — This Device Will REPLACE the MicrochipWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | SponsoredGENIUS Act: The Plot to Seize Your Cash?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ARYA Sciences Acquisition Corp II Please log in to your account or sign up in order to add this asset to your watchlist. Share ARYA Sciences Acquisition Corp II With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.